← Eichor
Study identifier: NCT04668872 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Condition: Colon Cancer Liver Metastasis · Colon Cancer · Adenocarcinoma of the Colon  ·  Sponsor: Memorial Sloan Kettering Cancer Center

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to study the way radioembolization works by collecting biopsy samples of participants' tumors after the procedure. This research may improve the way that radioembolization is performed, which could help people whose cancer has spread to the liver. The research may also provide information about how tumors respond to radioembolization.

This description comes directly from the study's public registry record.

Talk to the study team

Constantinos T Sofocleous, MD, PhD  ·  212-639-3379  ·  sofoclec@mskcc.org

Assen Kirov, PhD  ·  212-639-7126  ·  kirova@mskcc.org

Always discuss trial participation with your own doctor first.

Locations (1)

Memorial Sloan Kettering Cancer CenterNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04668872